Skip to main content
SpringerLink
Log in

The US Agency for Healthcare Research and Quality and the FDA are teaming up to assess the potential cardiovascular (CV) risk posed by drugs

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications. Media Release: 17 Sep 2007. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The US Agency for Healthcare Research and Quality and the FDA are teaming up to assess the potential cardiovascular (CV) risk posed by drugs. React. Wkly. 1171, 2 (2007). https://doi.org/10.2165/00128415-200711710-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711710-00003

Keywords

Search

Navigation